{"id":742069,"date":"2011-11-10T08:55:00","date_gmt":"2011-11-10T08:55:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/"},"modified":"2026-08-10T13:01:15","modified_gmt":"2026-08-10T17:01:15","slug":"merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/","title":{"rendered":"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth"},"content":{"rendered":"<ul>\n<li>         Reaffirms commitment to scientific innovation       <\/li>\n<li>         Highlights strong pipeline with near-term catalysts in 2012 and          2013       <\/li>\n<li>         Expresses confidence in near-term and long-term prospects       <\/li>\n<li>         Increases quarterly dividend 11 percent to $0.42 per common share       <\/li>\n<\/ul>\n<p>WHITEHOUSE STATION, N.J.&#8211;(BUSINESS WIRE)&#8211;Merck (NYSE: MRK), known as MSD outside the United States and Canada,        today is holding its R&amp;D and Business Briefing at its global        headquarters, highlighting the company&#8217;s research strategy, including        candidates from its R&amp;D pipeline, and providing an update on its plans        for growth.     <\/p>\n<p>       &#8220;Early in the year, we said 2011 would be all about executing our growth        plans,\u201d said Kenneth C. Frazier, president and chief executive officer,        \u201cand there can be no mistaking that Merck is doing just that. We are        implementing a four-part strategy to drive top-line and bottom-line        performance with the aim of realizing superior shareholder returns over        the longer term.     <\/p>\n<p>       &#8220;We are focused on making the right investment decisions across our        business while continuing to advance and augment our late-stage        pipeline. Fundamentally, Merck is about translating cutting-edge science        into medically important medicines and vaccines that save, extend and        improve lives throughout the world. Our strategy is based on innovation        being the single biggest driver of value over the long term for        patients, customers and shareholders.&#8221;     <\/p>\n<p>       <b>2011 &#8211; A Year of Accelerated Growth and Execution<\/b>     <\/p>\n<p>       As Merck entered 2011, the company focused on accelerating top-line        growth, reducing costs, allocating resources to drive growth and        advancing and augmenting its pipeline.     <\/p>\n<p>       \u201cThree consecutive quarters of top- and bottom-line growth, coupled with        strong expense management, demonstrate Merck&#8217;s ability to consistently        perform, while at the same time make the strategic investments necessary        for the future,\u201d said Frazier. For example:     <\/p>\n<ul>\n<li class=\"bwlistitemmargb\">         Through September 30, 2011, Merck delivered 5 percent top-line growth,          increasing sales by nearly $2 billion.       <\/li>\n<li class=\"bwlistitemmargb\">         Merck grew its non-GAAP EPS by 10 percent year to date, even after          reinvesting more than $500 million in growth opportunities and new          product launches.       <\/li>\n<li class=\"bwlistitemmargb\">         Since the merger with Schering-Plough, Merck achieved $2.8 billion in          net synergies.       <\/li>\n<\/ul>\n<p>       Thus far in 2011, Merck has received approval for five new drugs and has        filed for approval on five more. Additionally year to date, Merck signed        more than 30 agreements with a broad array of partners, many of which        strengthen the company\u2019s presence in emerging markets.     <\/p>\n<p>       &#8220;As we continue to implement our growth strategy, our aspiration for        next year is to advance an innovative R&amp;D pipeline, deliver strong        operating performance to maintain sales at or near the full-year 2011        level and continue reducing our costs to deliver a leveraged P&amp;L.&#8221;     <\/p>\n<p>       Merck intends to achieve long-term, sustainable growth by delivering on        its four-part strategy for creating shareholder value. Key elements of        the company&#8217;s strategic plan are as follows:     <\/p>\n<ul>\n<li class=\"bwlistitemmargb\">         Execute plans to optimize its core business, including maximizing the          growth of in-line products, launching new drugs and driving return on          investment across the R&amp;D portfolio.       <\/li>\n<li class=\"bwlistitemmargb\">         Grow in key markets around the world by building capabilities and          executing partnerships to succeed, especially in emerging markets.       <\/li>\n<li class=\"bwlistitemmargb\">         Extend the company\u2019s opportunities in its Animal Health and Consumer          Care businesses.       <\/li>\n<li class=\"bwlistitemmargb\">         Excel in managing costs to invest in smart growth opportunities that          will increase shareholder return.       <\/li>\n<\/ul>\n<p>       <b>Merck Increases Quarterly Dividend<\/b>     <\/p>\n<p>       \u201cLooking to 2012, we are confident that we are taking the right steps to        ensure that Merck is generating profitable sales growth to drive        improved returns and even greater cash flow than we do today,\u201d said        Frazier. \u201cReflecting confidence in our business and our commitment to        returning cash to shareholders, today the Merck Board of Directors        raised the company&#8217;s quarterly dividend by 11 percent.\u201d     <\/p>\n<p>       Merck&#8217;s quarterly dividend is being increased $0.04 from $0.38 per        outstanding share of the company&#8217;s common stock to $0.42 per common        share. The Board declared that the new dividend is payable January 9,        2012 to stockholders of record at the close of business on December 15,        2011.     <\/p>\n<p>       Since the beginning of 2010, Merck has returned over $9 billion to        shareholders in the form of dividends and repurchased about $3 billion        of Merck stock.     <\/p>\n<p>       Additional information about Merck&#8217;s R&amp;D and Business Briefing can be        found on <a target=\"_blank\" href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck.com&amp;esheet=50065387&amp;lan=en-US&amp;anchor=www.merck.com&amp;index=1&amp;md5=bb713b05f380595cb768e2f6901c9e42\">www.merck.com<\/a>.     <\/p>\n<p>       <b>About Merck<\/b>     <\/p>\n<p>       Today&#8217;s Merck is a global healthcare leader working to help the world be        well. Merck is known as MSD outside the United States and Canada.        Through our prescription medicines, vaccines, biologic therapies, and        consumer care and animal health products, we work with customers and        operate in more than 140 countries to deliver innovative health        solutions. We also demonstrate our commitment to increasing access to        healthcare through far-reaching policies, programs and partnerships. For        more information, visit <a target=\"_blank\" href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck.com&amp;esheet=50065387&amp;lan=en-US&amp;anchor=www.merck.com&amp;index=2&amp;md5=5fc5e1eba78b259779bc68e8835bcd7c\">www.merck.com<\/a>        and connect with us on Twitter, Facebook and YouTube.     <\/p>\n<p>       <b>Forward-Looking Statement<\/b>     <\/p>\n<p>       This news release includes \u201cforward-looking statements\u201d within the        meaning of the safe harbor provisions of the United States Private        Securities Litigation Reform Act of 1995. Such statements may include,        but are not limited to, statements about the benefits of the merger        between Merck and Schering-Plough, including future financial and        operating results, the combined company\u2019s plans, objectives,        expectations and intentions and other statements that are not historical        facts. Such statements are based upon the current beliefs and        expectations of Merck\u2019s management and are subject to significant risks        and uncertainties. Actual results may differ from those set forth in the        forward-looking statements.     <\/p>\n<p>       The following factors, among others, could cause actual results to        differ from those set forth in the forward-looking statements: the        possibility that the expected synergies from the merger of Merck and        Schering-Plough will not be realized, or will not be realized within the        expected time period; the impact of pharmaceutical industry regulation        and health care legislation; the risk that the businesses will not be        integrated successfully; disruption from the merger making it more        difficult to maintain business and operational relationships; Merck\u2019s        ability to accurately predict future market conditions; dependence on        the effectiveness of Merck\u2019s patents and other protections for        innovative products; the risk of new and changing regulation and health        policies in the U.S. and internationally and the exposure to litigation        and\/or regulatory actions.     <\/p>\n<p>       Merck undertakes no obligation to publicly update any forward-looking        statement, whether as a result of new information, future events or        otherwise. Additional factors that could cause results to differ        materially from those described in the forward-looking statements can be        found in Merck\u2019s 2010 Annual Report on Form 10-K and the company\u2019s other        filings with the Securities and Exchange Commission (SEC) available at        the SEC\u2019s Internet site (<a target=\"_blank\" href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=50065387&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=3&amp;md5=3f22889e938bffbd9463d338c99cd662\">www.sec.gov<\/a>).     <\/p>\n<p class=\"bwalignc\">\n<p><p>       Merck<br \/>Media:<br \/>David Caouette, 908-423-3461<br \/>or<br \/>Investor:<br \/>Alex        Kelly, 908-423-5185     <\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reaffirms commitment to scientific innovation Highlights strong pipeline with near-term catalysts in 2012 and 2013 Expresses confidence in near-term and long-term prospects Increases quarterly dividend 11 percent to $0.42 per common share Merck (NYSE: MRK), known as MSD outside the United States and Canada, today is holding its R&amp;D and Business Briefing at its global headquarters, highlighting the company&#8217;s research strategy, including candidates from its R&amp;D pipeline, and providing an update on its plans for growth. &#8220;Early in the year, we said 2011 would be all about executing our growth plans,\u201d said Kenneth C. Frazier, president and chief executive officer, \u201cand there can be no mistaking that Merck is doing just that. We are implementing a four-part strategy to drive top-line and bottom-line performance with the aim of realizing superior shareholder returns over the longer term. &#8220;We are focused on making the right investment decisions across our business while continuing to advance<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,289],"class_list":["post-742069","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Reaffirms commitment to scientific innovation Highlights strong pipeline with near-term catalysts in 2012 and 2013 Expresses confidence in near-term and long-term prospects Increases quarterly dividend 11 percent to $0.42 per common share Merck (NYSE: MRK), known as MSD outside the United States and Canada, today is holding its R&amp;D and Business Briefing at its global headquarters, highlighting the company&#039;s research strategy, including candidates from its R&amp;D pipeline, and providing an update on its plans for growth. &quot;Early in the year, we said 2011 would be all about executing our growth plans,\u201d said Kenneth C. Frazier, president and chief executive officer, \u201cand there can be no mistaking that Merck is doing just that. We are implementing a four-part strategy to drive top-line and bottom-line performance with the aim of realizing superior shareholder returns over the longer term. &quot;We are focused on making the right investment decisions across our business while continuing to advance\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-10T17:01:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3056\" \/>\n\t<meta property=\"og:image:height\" content=\"1380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\\\/\",\"name\":\"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"datePublished\":\"2011-11-10T08:55:00+00:00\",\"dateModified\":\"2026-08-10T17:01:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/","og_locale":"en_US","og_type":"article","og_title":"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth - Merck.com","og_description":"Reaffirms commitment to scientific innovation Highlights strong pipeline with near-term catalysts in 2012 and 2013 Expresses confidence in near-term and long-term prospects Increases quarterly dividend 11 percent to $0.42 per common share Merck (NYSE: MRK), known as MSD outside the United States and Canada, today is holding its R&amp;D and Business Briefing at its global headquarters, highlighting the company's research strategy, including candidates from its R&amp;D pipeline, and providing an update on its plans for growth. \"Early in the year, we said 2011 would be all about executing our growth plans,\u201d said Kenneth C. Frazier, president and chief executive officer, \u201cand there can be no mistaking that Merck is doing just that. We are implementing a four-part strategy to drive top-line and bottom-line performance with the aim of realizing superior shareholder returns over the longer term. \"We are focused on making the right investment decisions across our business while continuing to advance","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/","og_site_name":"Merck.com","article_modified_time":"2026-08-10T17:01:15+00:00","og_image":[{"width":3056,"height":1380,"url":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/","name":"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"datePublished":"2011-11-10T08:55:00+00:00","dateModified":"2026-08-10T17:01:15+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"5bfd1611-5e8c-4943-9711-cac0a9ec9f19","news_item_aria_label":"","media_files":null,"document_path":"","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742069\/revisions"}],"predecessor-version":[{"id":3679205,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742069\/revisions\/3679205"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=742069"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=742069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}